IGM Biosciences Inc (NAS:IGMS)
$ 17.25 -0.57 (-3.2%) Market Cap: 1.02 Bil Enterprise Value: 840.64 Mil PE Ratio: 0 PB Ratio: 8.34 GF Score: 30/100

IGM Biosciences Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 04:40PM GMT
Release Date Price: $94.47 (+7.23%)
Felipe Velasquez
JP Morgan Chase & Co. - VP of Healthcare Investment Banking

Good morning, and welcome, everyone, to the 39th Annual JPMorgan Healthcare Conference. My name is Felipe Velasquez, the Vice President on our Healthcare Investment Banking team. I'm here with our next presenting company, CEO, Fred Schwarzer, of IGM Biosciences.

As a reminder to those watching the presentation, if you would like to ask a question afterwards, please submit one via the Ask a link -- Ask-a-question link found under the viewing panel of your screen.

I'll now turn it over to Fred.

Fred M. Schwarzer
IGM Biosciences, Inc. - CEO, President & Director

Thanks very much, Felipe. It's my honor and pleasure to be able to present IGM Biosciences today.

Second slide. This is our forward-looking statement disclosure, which basically advises you to take a look at our filings with the SEC, including the Risk Factors sections. And those will help explain that sometimes, things can happen, and our best hopes and plans don't necessarily always work

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot